BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 7796409)

  • 1. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
    Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP
    Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
    Campbell MJ; Reddy GS; Koeffler HP
    J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines.
    Koike M; Elstner E; Campbell MJ; Asou H; Uskokovic M; Tsuruoka N; Koeffler HP
    Cancer Res; 1997 Oct; 57(20):4545-50. PubMed ID: 9377567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells.
    Shao ZM; Dawson MI; Li XS; Rishi AK; Sheikh MS; Han QX; Ordonez JV; Shroot B; Fontana JA
    Oncogene; 1995 Aug; 11(3):493-504. PubMed ID: 7630633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
    Gniadecki R
    Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
    Mathiasen IS; Lademann U; Jäättelä M
    Cancer Res; 1999 Oct; 59(19):4848-56. PubMed ID: 10519395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.
    Liu J; Jiang Z; Xiao J; Zhang Y; Lin S; Duan W; Yao J; Liu C; Huang X; Wang T; Liang Z; Wang R; Zhang S; Zhang L
    Phytomedicine; 2009 Nov; 16(11):1006-13. PubMed ID: 19524422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
    Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
    Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.
    Brosseau C; Colston K; Dalgleish AG; Galustian C
    Apoptosis; 2012 Feb; 17(2):164-73. PubMed ID: 22109882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
    Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells.
    Eisman JA; Sutherland RL; McMenemy ML; Fragonas JC; Musgrove EA; Pang GY
    J Cell Physiol; 1989 Mar; 138(3):611-6. PubMed ID: 2925799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status.
    Brodowicz T; Kandioler D; Tomek S; Ludwig C; Rudas M; Kunstfeld R; Koestler W; Hejna M; Budinsky A; Wiltschke C; Zielinski CC
    Br J Cancer; 2001 Nov; 85(11):1764-70. PubMed ID: 11742500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
    Koga M; Eisman JA; Sutherland RL
    Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 1,25(OH)2D3 on the growth and apoptosis of breast cancer cell line MCF-7.
    Zhang J; Yao Z
    Chin Med J (Engl); 2000 Feb; 113(2):124-8. PubMed ID: 11775534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.